CytomX CTMX Analyst; Cvrx CVRX Earnings

BioPharmCatalystMay 2 04:03

Lake Street: Maintains CVRx (CVRX.US) rating, adjusted from buy to buy rating, and adjusted target price from $35.00 to $18.00.

Lake Street: Maintains CVRx (CVRX.US) rating, adjusted from buy to buy rating, and adjusted target price from $35.00 to $18.00.

Zhitong FinanceMay 2 03:50

Sector Update: Health Care

Health care stocks advanced late Wednesday afternoon with the NYSE Health Care Index rising 0.9% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.7%. The iShares Biotechnology ETF (IBB) cli

MT NewswiresMay 2 03:35

CVRx Is Maintained at Buy by Canaccord Genuity

CVRx Is Maintained at Buy by Canaccord Genuity

Dow JonesMay 2 03:02

Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Wednesday. The Federal Reserve opted to keep the federal funds rate unchanged at 5.25% to 5.5%,

BenzingaMay 2 02:32

Top Midday Decliners

Cemtrex (CETX) unveiled the pricing of an underwritten offering, with gross proceeds likely to be about $10 million and upsized from $9 million. Shares slumped 72.5% as intraday trading volume soared

MT NewswiresMay 2 02:29